Sphk1 participates in malignant progression of breast cancer by regulating epithelial-mesenchymal transition and stem cell characteristics
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 65, 101380
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The relevance of EMT in breast cancer metastasis: Correlation or causality?FEBS Letters, 2015
- N-cadherin mediates the migration of MCF-10A cells undergoing bone morphogenetic protein 4-mediated epithelial mesenchymal transitionTumor Biology, 2014
- Breast cancer stem cells, EMT and therapeutic targetsBiochemical and Biophysical Research Communications, 2014
- A review of clinical aspects of breast cancerInternational Review of Psychiatry, 2014
- Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK InhibitorsJournal of Medicinal Chemistry, 2014
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal CounterpartsStem Cell Reports, 2014
- Sphingosine 1-phosphate signallingDevelopment, 2014
- Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2−ΔΔCT methodMolecular and Cellular Biochemistry, 2011
- Western BlottingClinical Chemistry, 2011
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008